Lidy van Aalten

Statistics

Publications

Citations

387

H-Index

Active since

2007

Affiliations

Ninewells Hospital(Current)

University of Dundee

University of Manchester

University College London

GlaxoSmithKline (United Kingdom)

Lidy van Aalten is an author at Ninewells Hospital specializing in life sciences, glycogen synthase kinase 3 regulation, and glycogen synthase kinase regulation.

Publications per year

2007–2024

Publications

Collapsin response mediator protein‐2 hyperphosphorylation is an early event in Alzheimer’s disease progression

Adam R. Cole, Wendy Noble, Lidy van Aalten et al. · Journal of Neurochemistry · 2007 · 172 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

CRMP2 Hyperphosphorylation is Characteristic of Alzheimer's Disease and not a Feature Common to Other Neurodegenerative Diseases

Ritchie Williamson, Lidy van Aalten, David M. A. Mann et al. · Journal of Alzheimer s Disease · 2011 · 65 citations

Life Sciences, Neurobiology, Neuroscience +9

Relative Resistance of Cdk5-phosphorylated CRMP2 to Dephosphorylation

Adam R. Cole, Marc P. M. Soutar, Makoto Rembutsu et al. · Journal of Biological Chemistry · 2008 · 48 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Recruitment, Retainment, and Biomarkers of Response; A Pilot Trial of Lithium in Humans With Mild Cognitive Impairment

Ashleigh C. Duthie, Lidy van Aalten, C. F. Macdonald et al. · Frontiers in Molecular Neuroscience · 2019 · 26 citations · Full text

Medicine, Neurology, Pharmacology +17

Inhibition of glycogen synthase kinase-3 enhances NRF2 protein stability, nuclear localisation and target gene transcription in pancreatic beta cells

Chinmai Patibandla, Lidy van Aalten, Albena T. Dinkova‐Kostova et al. · Redox Biology · 2024 · 26 citations · Full text

Life Sciences, Biochemistry, Cell Biology +16

1–5 of 8